logo

For the Inventor, By the Inventor

Koln, Germany

Henning Sommermeyer

USPTO Granted Patents = 25

Average Co-Inventor Count = 7.4

ph-index = 7

Forward Citations = 171(Granted Patents)


Location History:

  • Cologne, DE (1994 - 1999)
  • Koln, DE (1996 - 2000)
  • Köln, DE (2001)

Company Filing History:

goldMedal25 out of 12,160 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1994-2001

Loading Chart...
25 patents (USPTO):Explore Patents
1. 6194428 - Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system (2001-02-27),
2. 6147087 - Use of 1,2-Bridged 1,4-dihydropyridines as medicaments (2000-11-14),
3. 6121284 - 2,3-bridged 1,4-dihydropyridines, and their use as medicaments (2000-09-19),
4. 6060482 - Triazaspirodecanone-methylchromans (2000-05-09),
5. 5990121 - Use of 1,2-bridged 1,4-dihydropyridines as medicaments (1999-11-23),
6. 5962513 - 2-aminomethyl-chromans effective in the treatment of psychoses and (1999-10-05),
7. 5955482 - Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments (1999-09-21),
8. 5942526 - 5-acyl-1,4-dihydropyridines (1999-08-24),
9. 5874462 - Use of substituted 6-amino-4H-pyrans (1999-02-23),
10. 5861394 - Use of N-substituted phenothiazines (1999-01-19),
11. 5756515 - Dioxo-thiopyrano-pyridine-carboxylic acid derivatives and their use as (1998-05-26),
12. 5696137 - Azaheterocyclymethyl-chromans (1997-12-09),
13. 5696136 - Method of treating psychosis using azaheterocyclylmethyl (1997-12-09),
14. 5693653 - Method of treating depression using azaheterocyclylmethyl-chromans (1997-12-02),
15. 5670525 - Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the (1997-09-23),

Title: Innovations in Medicinal Chemistry: The Contributions of Henning Sommermeyer

Introduction

Henning Sommermeyer, based in Cologne, Germany, is a distinguished inventor with a remarkable portfolio of 25 patents in the field of medicinal chemistry. His pioneering work focuses on the development of innovative compounds that target diseases of the central nervous system, positioning him as a significant figure in pharmaceutical research.

Latest Patents

Among his latest patents, Sommermeyer's work includes the “Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system.” This invention leverages specific chemical compounds to develop medicaments aimed at treating cerebral disorders. Another noteworthy patent is the “Use of 1,2-Bridged 1,4-dihydropyridines as medicaments.” This invention explores the use of known 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators, highlighting their potential in addressing central nervous system disorders.

Career Highlights

Sommermeyer is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His contributions have significantly advanced the understanding of medicinal applications of various chemical compounds, reflecting both innovation and dedication in his field.

Collaborations

Throughout his career, Sommermeyer has collaborated with notable peers such as Hans-Georg Heine and Thomas Glaser. These collaborations have facilitated the exchange of ideas and expertise, further enhancing the potential impact of their collective research efforts in the pharmaceutical industry.

Conclusion

Henning Sommermeyer's contributions to medicinal chemistry exemplify the critical role of innovation in improving healthcare outcomes. His extensive patent portfolio not only showcases his ingenuity but also reflects the collaborative effort in advancing scientific knowledge in treating central nervous system diseases. His work continues to inspire future research and innovation within the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…